Solventum Corporation (SOLV) Covered Calls
Solventum is a leading global healthcare company that spun off from 3M in 2024 to focus on innovative solutions in medtech and health information systems. The company operates through four primary segments: Medical Surgical, Dental Solutions, Health Information Systems, and Purification and Filtration. With a legacy of over 7,300 patents, Solventum aims to enhance patient outcomes and improve healthcare efficiency worldwide.
You can sell covered calls on Solventum Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SOLV (prices last updated Fri 4:16 PM ET):
| Solventum Corporation (SOLV) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 69.41 | -1.37 | 68.00 | 70.00 | 1.3M | 8.0 | 12 |
| Covered Calls For Solventum Corporation (SOLV) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Mar 20 | 70 | 1.10 | 68.90 | 1.6% | 38.9% | |
| Apr 17 | 70 | 2.10 | 67.90 | 3.1% | 26.3% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Solventum Corporation is a global healthcare giant that emerged as an independent public entity in 2024 through the spin-off of 3M Company’s healthcare business. Headquartered in St. Paul, Minnesota, Solventum is a diversified medtech leader, leveraging a vast intellectual property portfolio to solve the most difficult challenges at the intersection of material science, digital health, and clinical workflows.
The company’s operations are organized into four mission-critical segments:
- Medical Surgical (MedSurg): The largest revenue driver, providing advanced wound care, negative pressure wound therapy, and infection prevention products utilized in millions of treatments annually.
- Dental Solutions: A global leader in restorative and orthodontic materials, including the iconic Filtek and Clarity brands, serving practitioners in over 90 countries.
- Health Information Systems: Delivering AI-powered software solutions for clinical documentation and revenue cycle management, currently utilized by approximately 75% of U.S. hospitals.
- Purification & Filtration: Specialized in high-performance membranes and filters for biopharmaceutical manufacturing and life-saving dialysis treatments.
The competitive landscape for Solventum is defined by large-scale medical device firms and specialized dental or software providers. In the dental and orthodontic space, the company competes directly with Align Technology and Henry Schein. In the medical-surgical and contact lens/filtration segments, it frequently vies for market share against Baxter International and The Cooper Companies. Additionally, the company faces growing competition from healthcare-focused tech giants in the clinical AI and data analytics space.
Strategic Outlook and Innovation
Solventum is currently executing a "Transformation Plan" designed to accelerate organic growth through commercial restructuring and portfolio optimization. A major strategic pillar is the integration of the recently acquired Acera Surgical, which bolsters the company’s advanced wound care capabilities with innovative "synthetic" tissue technologies. Innovation efforts are also focused on the launch of AI-driven diagnostic tools for the dental market and the expansion of autonomous coding features within its Health Information Systems platform to reduce administrative waste in hospitals. By divesting non-core business units, such as its industrial filtration arm, and reinvesting in higher-margin medtech sectors, Solventum intends to improve its financial flexibility and deliver best-in-class clinical solutions that lower the total cost of care while improving patient recovery speeds.
| Top 10 Open Interest For Mar 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | CTMX covered calls | |
| 2. | SLV covered calls | 7. | EWZ covered calls | 2. | MRVL covered calls | |
| 3. | EEM covered calls | 8. | GLD covered calls | 3. | REPL covered calls | |
| 4. | SPY covered calls | 9. | FXI covered calls | 4. | QURE covered calls | |
| 5. | IBIT covered calls | 10. | SOFI covered calls | 5. | PATH covered calls | |
Want more examples? SOLS Covered Calls | SON Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
